[1] SEIZ J R, KLINKE J, SCHARLIBBE L, et al. Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma[J]. Biol Chem, 2020, 401(4):517-531.
[2] MATTILA P K, LAPPALAINEN P. Filopodia:molecular architecture and cellular functions[J]. Nat Rev Mol Cell Biol, 2008, 9(6):446-454.
[3] 利尔加斯. 结构生物学[M]. 北京:科学出版社, 2013:148-149.
[4] RAPTIS L, ARULANANDAM R, GELETU M, et al. The R(h)oads to Stat3:Stat3 activation by the rho GTPases[J]. Exp Cell Res, 2011, 317(13):1787-1795.
[5] ZHENG C W, ZENG R J, XU L Y, et al. Rho GTPases:Promising candidates for overcoming chemotherapeutic resistance[J]. Cancer Lett, 2020, 475:65-78.
[6] QU H, SUN H, WANG X. Neogenin-1 promotes cell proliferation, motility, and adhesion by up-regulation of zinc finger E-box binding homeobox 1 via activating the Rac1/PI3K/AKT pathway in gastric cancer cells[J]. Cell Physiol Biochem, 2018, 48(4):1457-1467.
[7] LI Z, WANG Q, PENG S, et al. The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling[J]. Clin Transl Med, 2020, 10(6):e191.
[8] LI Z C, ZHANG L Y, GAO M Q, et al. Retraction Note:Endoplasmic Reticulum stress triggers Xanthoangelol-induced protective autophagy via activation of JNK/c-Jun Axis in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2020, 39(1):164.
[9] ZHANG L, LIANG H, XIN Y. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway[J]. Anticancer Drugs, 2020, 31(8):847-855.
[10] LI Z, WANG Q, PENG S, et al. The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling[J]. Clin Transl Med, 2020, 10(6):e191.
[11] MENG Q H, XIA Y. C-Jun, at the crossroad of the signaling network[J]. Protein Cell, 2011, 2(11):889-898.
[12] DAVIS R J. Signal transduction by the JNK group of MAP kinases[J]. Cell, 2000, 103(2):239-252.
[13] BEHRENS A, SIBILIA M, DAVID J P, et al. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-Jun in the liver[J]. EMBO J, 2002, 21(7):1782-1790.
[14] RIERA-SANS L, BEHRENS A. Regulation of alphabeta/gammadelta T cell development by the activator protein 1 transcription factor c-Jun[J]. J Immunol, 2007, 178(9):5690-5700.
[15] MATTILA P K, LAPPALAINEN P. Filopodia:molecular architecture and cellular functions[J]. Nat Rev Mol Cell Biol, 2008, 9(6):446-454.
[16] SAYYAD W A, FABRIS P, TORRE V. The role of Rac1 in the growth cone dynamics and force generation of DRG neurons[J]. PLoS One, 2016, 11(1):e0146842.
[17] OLSON H M, NECHIPORUK A V. Lamellipodia-like protrusions and focal adhesions contribute to collective cell migration in zebrafish[J]. Dev Biol, 2021, 469:125-134.
[18] MOHAN A S, DEAN K M, ISOGAI T, et al. Enhanced dendritic actin network formation in extended lamellipodia drives proliferation in growth-challenged Rac1P29S melanoma cells[J]. Dev Cell, 2019, 49(3):444-460.e9.
[19] TOMASEVIC N, JIA Z, RUSSELL A, et al. Differential regulation of wasp and n-wasp by Cdc42, Rac1, nck, and PI(4, 5)P2[J]. Biochemistry, 2007, 46(11):3494-3502.
[20] HUEHN A R, BIBEAU J P, SCHRAMM A C, et al. Structures of cofilin-induced structural changes reveal local and asymmetric perturbations of actin filaments[J]. Proc Natl Acad Sci USA, 2020, 117(3):1478-1484.
[21] MIERKE C T, PUDER S, AERMES C, et al. Effect of PAK inhibition on cell mechanics depends on Rac1[J]. Front Cell Dev Biol, 2020, 8:13.
[22] MITRA S K, HANSON D A, SCHLAEPFER D D. Focal adhesion kinase:in command and control of cell motility[J]. Nat Rev Mol Cell Biol, 2005, 6(1):56-68.
[23] LÓPEZ-COLOMÉ A M, LEE-RIVERA I, BENAVIDES-HIDALGO R, et al. Paxillin:a crossroad in pathological cell migration[J]. J Hematol Oncol, 2017, 10(1):50.
[24] CHATTERJEE A, GHOSH J, RAMDAS B, et al. Regulation of Stat5 by FAK and PAK1 in oncogenic FLT3- and KIT-driven leukemogenesis[J]. Cell Rep, 2014, 9(4):1333-1348.
[25] ZENG Y, REN M, LI Y, et al. Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway[J]. Cancer Lett, 2020, 492:136-146.
[26] LI Y, ZHAO M, GUO C, et al. Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation[J]. Oncogene, 2018, 37(8):1095-1106.
[27] CISCATO F, FILADI R, MASGRAS I, et al. Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca2+-dependent death of cancer cells[J]. EMBO Rep, 2020, 21(7):e49117.
[28] CHRISTOFK H R, VANDER HEIDEN M G, HARRIS M H, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth[J]. Nature, 2008, 452(7184):230-233.
[29] CHENG A, ZHANG P, WANG B, et al. Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect[J]. Nat Commun, 2019, 10(1):5566.
[30] HIROTA K, SEMENZA G L. Rac1 activity is required for the activation of hypoxia-inducible factor 1[J]. J Biol Chem, 2001, 276(24):21166-21172.
[31] LI Q, QIN T, BI Z, et al. Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer[J]. Nat Commun, 2020, 11(1):1456.
[32] ZENG R J, ZHENG C W, GU J E, et al. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes[J]. Mol Oncol, 2019, 13(9):2010-2030.
[33] CANNON A C, URIBE-ALVAREZ C, CHERNOFF J. RAC1 as a therapeutic target in malignant melanoma[J]. Trends Cancer, 2020, 6(6):478-488. |
